What can genetically informative designs add to the understanding of ADHD?
Author: Chen, Qi
Date: 2016-03-18
Location: Hörsal Petrén, Nobels väg 12B, Karolinska Institutet, Solna
Time: 09.00
Department: Inst för medicinsk epidemiologi och biostatistik / Dept of Medical Epidemiology and Biostatistics
View/ Open:
Thesis (2.344Mb)
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent and clinically
heterogeneous neurodevelopmental disorder affecting approximately 3.4–7.3% children and
adolescents and 2.5–3.4% adults worldwide, leading to adverse consequences for affected
individuals, their families, and society at large. Despite the growing body of research, the
etiology of ADHD remains obscure. Epidemiologic research is crucial for detecting disease
risk factors. However, prior studies have rarely moved beyond identifying associations
between proposed risk factors and later outcomes to rigorously testing the causality of these
associations. The stagnation is partly due to the intrinsic limitations of observational studies,
such as insufficient adjustment for genetic confounding. Large register-based data enable
researchers to incorporate classical epidemiologic designs into genetically informative
samples. Such genetically informative study designs are useful tools for unraveling the role of
genetic and environmental factors in the development of diseases. In this thesis, the four
studies used genetically informative designs to enhance the current understanding of the
etiology of ADHD and the mechanisms underlying the associations between ADHD and its
adverse health outcomes, including high body mass index (BMI) and suicidal behavior.
In Study I, we attempted to quantify the familial aggregation of ADHD in a large representative Swedish family sample, consisting of siblings and cousins of varying degrees of genetic relatedness. The results demonstrated that the familial aggregation of ADHD generally increased with increasing genetic relatedness between family members. Persistence of ADHD into adulthood in family members was associated with higher degree of the familial aggregation compared to remission of ADHD prior to adulthood.
In Study II, we assessed the co-aggregation of ADHD and overweight/obesity within families and further tested the hypothesis that the familial co-aggregation of the two conditions is at least in part due to common familial causes. The findings suggested an etiological overlap between ADHD and overweight/obesity.
In Study III, we investigated the association between high maternal pre-pregnancy BMI and offspring ADHD both at the population level and within siblings. The findings indicated the contribution of shared familial factors to the association, which supported the conclusion from Study II. A direct causal effect of high maternal pre-pregnancy BMI on offspring ADHD was, however, not evident.
In Study IV we examined the association between the use of ADHD medication and concomitant suicidal behavior. When the same individual was compared with him of herself for the rate of suicide-related events during on- and off-treatment periods, the results did not support that the use of ADHD medication increased the risk of concomitant suicidal behavior.
In conclusion, observational studies using genetically informative designs may provide valuable insights into the etiology of ADHD. The familial aggregation of ADHD increases with increasing genetic relatedness. ADHD and overweight/obesity share etiological factors. In family settings, such shared etiological factors lead to the familial co-aggregation of the two conditions. Moreover, the shared etiological factors manifest as unmeasured familial confounding, which may partly account for the population-level association between high maternal pre-pregnancy BMI and offspring ADHD. The use of ADHD medication does not appear to increase the risk of concomitant suicidal behavior. Genetically informative designs should be increasingly used in future epidemiologic research to efficiently control for confounding and strengthen causal inferences.
In Study I, we attempted to quantify the familial aggregation of ADHD in a large representative Swedish family sample, consisting of siblings and cousins of varying degrees of genetic relatedness. The results demonstrated that the familial aggregation of ADHD generally increased with increasing genetic relatedness between family members. Persistence of ADHD into adulthood in family members was associated with higher degree of the familial aggregation compared to remission of ADHD prior to adulthood.
In Study II, we assessed the co-aggregation of ADHD and overweight/obesity within families and further tested the hypothesis that the familial co-aggregation of the two conditions is at least in part due to common familial causes. The findings suggested an etiological overlap between ADHD and overweight/obesity.
In Study III, we investigated the association between high maternal pre-pregnancy BMI and offspring ADHD both at the population level and within siblings. The findings indicated the contribution of shared familial factors to the association, which supported the conclusion from Study II. A direct causal effect of high maternal pre-pregnancy BMI on offspring ADHD was, however, not evident.
In Study IV we examined the association between the use of ADHD medication and concomitant suicidal behavior. When the same individual was compared with him of herself for the rate of suicide-related events during on- and off-treatment periods, the results did not support that the use of ADHD medication increased the risk of concomitant suicidal behavior.
In conclusion, observational studies using genetically informative designs may provide valuable insights into the etiology of ADHD. The familial aggregation of ADHD increases with increasing genetic relatedness. ADHD and overweight/obesity share etiological factors. In family settings, such shared etiological factors lead to the familial co-aggregation of the two conditions. Moreover, the shared etiological factors manifest as unmeasured familial confounding, which may partly account for the population-level association between high maternal pre-pregnancy BMI and offspring ADHD. The use of ADHD medication does not appear to increase the risk of concomitant suicidal behavior. Genetically informative designs should be increasingly used in future epidemiologic research to efficiently control for confounding and strengthen causal inferences.
List of papers:
I. Chen Q, Brikell I, Lichtenstein P, Serlachius E, Kuja-Halkola R, Sandin S, Larsson H. Family Aggregation of ADHD. [Submitted]
II. Chen Q, Kuja-Halkola R, Sjölander A, Serlachius E, Cortese S, Faraone SV., Almqvist C, Larsson H. Etiological overlap of ADHD and Obesity. [Submitted]
III. Chen Q, Sjolander A, Langstrom N, Rodriguez A, Serlachius E, D'Onofrio BM, Lichtenstein P, Larsson H. Maternal pre-pregnancy body mass index and offspring attention deficit hyperactivity disorder : a population-based cohort study using a sibling-comparison design. Int J Epidemiol. 2014;43(1):83-90.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Chen Q, Sjolander A, Runeson B, D'Onofrio BM, Lichtenstein P, Larsson H. Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour : register based study. BMJ. 2014;348:g3769
Fulltext (DOI)
Pubmed
View record in Web of Science®
I. Chen Q, Brikell I, Lichtenstein P, Serlachius E, Kuja-Halkola R, Sandin S, Larsson H. Family Aggregation of ADHD. [Submitted]
II. Chen Q, Kuja-Halkola R, Sjölander A, Serlachius E, Cortese S, Faraone SV., Almqvist C, Larsson H. Etiological overlap of ADHD and Obesity. [Submitted]
III. Chen Q, Sjolander A, Langstrom N, Rodriguez A, Serlachius E, D'Onofrio BM, Lichtenstein P, Larsson H. Maternal pre-pregnancy body mass index and offspring attention deficit hyperactivity disorder : a population-based cohort study using a sibling-comparison design. Int J Epidemiol. 2014;43(1):83-90.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Chen Q, Sjolander A, Runeson B, D'Onofrio BM, Lichtenstein P, Larsson H. Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour : register based study. BMJ. 2014;348:g3769
Fulltext (DOI)
Pubmed
View record in Web of Science®
Institution: Karolinska Institutet
Supervisor: Larsson, Henrik
Issue date: 2016-02-23
Rights:
Publication year: 2016
ISBN: 978-91-7676-202-8
Statistics
Total Visits
Views | |
---|---|
What ... | 985 |
What ...(legacy) | 891 |
Total Visits Per Month
September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | |
---|---|---|---|---|---|---|---|
What ... | 10 | 33 | 16 | 22 | 23 | 19 | 20 |
File Visits
Views | |
---|---|
Thesis_Qi_Chen.pdf | 427 |
Thesis_Qi_Chen.pdf(legacy) | 339 |
Top country views
Views | |
---|---|
United States | 414 |
Sweden | 385 |
Denmark | 158 |
United Kingdom | 100 |
Germany | 94 |
Australia | 75 |
China | 72 |
Ireland | 69 |
France | 29 |
South Korea | 29 |
Top cities views
Views | |
---|---|
Ashburn | 107 |
Stockholm | 72 |
Copenhagen | 69 |
Dublin | 68 |
Sydney | 61 |
Örebro | 42 |
Ballerup | 26 |
Seoul | 21 |
Degerfors | 20 |
Kiez | 19 |